Wednesday, April 23, 2014

Novadaq revenue up 57% in Q4

Novadaq revenue up 57% in Q4

February 6, 2014 by · Leave a Comment 

Tweet Novadaq Technologies (NASDAQ:NVDQ; TSX:NDQ) has reported fourth quarter revenue of $10.7-million, a 57% year-over-year gain, bringing revenue for all of 2013 to $35-million, an increase of 52%, compared with 2012. Growth was driven by increases in the number of patients treated using the company’s fluorescence imaging technologies, and increases in capital sales of its […]

Novadaq Q1 revenue jumps 53%

Novadaq Q1 revenue jumps 53%

April 29, 2013 by · Leave a Comment 

Tweet Novadaq Technologies (NASDAQ:NVDQ; TSX:NDQ) revenue in the first quarter of 2013 totaled $7.3-million, an increase of 53%, compared with the first quarter of 2012. Revenue growth was driven primarily by continued adoption of SPY Elite procedures and higher FIREFLY system sales to end users. First quarter gross profit of $4.5-million (62% margin), represents an […]

Novadaq highlights game changer for the OR

Novadaq highlights game changer for the OR

October 16, 2012 by · Leave a Comment 

Tweet With adoption of its SPY imaging technologies growing in operating rooms across North America, Novadaq Technologies (NASDAQ:NVDQ; TSX:NDQ) has embarked on a long-term growth plan to image nerves and cancer cells with tissue-binding reagents that could represent a paradigm shift in the OR. “The future of the installed base of SPY technologies will include […]

Novadaq SPY Imaging gets CMS payment under OPPS

Novadaq SPY Imaging gets CMS payment under OPPS

March 7, 2012 by · Leave a Comment 

Tweet Novadaq Technologies (NASDAQ:NVDQ; TSX:NDQ) says that the Centers for Medicare & Medicaid Services (CMS) has established SPY Vascular Angiography as a new reimbursable service under the Hospital Outpatient Prospective Payment System (OPPS). Effective April 1, 2012, SPY is assigned to Ambulatory Payment Classification (APC) 0397 Vascular Imaging. “CMS has recognized SPY Imaging as a […]

Google+